Studies have shown that SCD inhibitors play a beneficial role by reducing the oleic acid concentration in animal models of Parkinson's disease [46], Alzheimer's disease [47], and demyelinating disorders [14]. Here, SCD is linked to early-onset autosomal dominant Alzheimer disease.